Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant Avastin and Taxotere in High-Risk Prostate Cancer
NCT00321646Phase 2Completed
- Start
- Jun 2006
- Primary completion
- Nov 2008
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in prostate cancer (PCa). Started Jun 2006; status: completed.
02
Drugs
bevacizumab
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00321646.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00321646.